Calendar of Events Mobile Version

Charles Serhan, Ph.D., professor and director, Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital; The Simon Gelman Professor of Anaesthesia (biochemistry and molecular pharmacology), Harvard Medical School

Lera Boroditsky, Ph.D., associate professor, University of California, San Diego

Kathleen Collins, Ph.D., professor, department of molecular and cell biology, University of California, Berkeley

Ian Chambers, Ph.D., professor of pluripotent stem cell biology, University of Edinburgh

Marion Pepper, Ph.D., associate professor, department of immunology, University of Washington

Jay Keasling, Ph.D., professor, department of chemical and biomolecular engineering, professor, department of bioengineering, The Hubbard Howe Jr. Distinguished Professor of Biochemical Engineering, senior faculty scientist, Lawrence Berkeley National Laboratory, chief executive officer, Joint BioEnergy Institute (JBEI), University of California, Berkeley

Lewis Cantley, Ph.D., Meyer Director of the Sandra and Edward Meyer Cancer Center, professor of cancer biology in medicine, Weill Cornell Medicine and NewYork-Presbyterian Hospital, PI 3-Kinase and Cancer Metabolism

Dafna Bar-Sagi, Ph.D., senior vice president and vice dean for science, chief scientific officer, professor, departments of biochemistry and molecular pharmacology, medicine, New York University School of Medicine, Oncogenic Ras-dependent Determinants of Tumor Fitness

Golnaz Vahedi, Ph.D., M.Sc., assistant professor of genetics, University of Pennsylvania, Exploiting Chromatin Biology to Understand Gene Regulation in T Cells

Ming Li, Ph.D., member, immunology program, Memorial Sloan Kettering Cancer Center, Immunity and Tolerance in Cancer

Carol Prives, Ph.D., Da Costa Professor, department of cell and molecular biology, Columbia University, Travels with p53 and Mdm2—and Some Surprises along the Way

Christopher Vakoc, M.D., Ph.D., principal investigator, associate professor, Cold Spring Harbor Laboratory, Lineage Reprogramming in Cancer

Miriam Merad, M.D., Ph.D., professor of oncological science, medicine, and immunology, member, Immunology Institute and The Tisch Cancer Institute, Mount Sinai School of Medicine, Mapping Myeloid Cell Contribution to Cancer Lesions

Jedd Wolchok, M.D., Ph.D., chief, melanoma and immunotherapeutics service, member and attending physician, Memorial Sloan Kettering Cancer Center, Immunologic Checkpoint Blockade: Dissecting Mechanisms and Next Steps

Jordan Orange, M.D., Ph.D., chair of pediatrics, Columbia University

Yumiko Saga, Ph.D., professor, Mammalian Development Laboratory, National Institute of Genetics, Mishima, Japan

Tami Lieberman, Ph.D., assistant professor, Massachusetts Institute of Technology

Bo Li, Ph.D., assistant professor, department of chemistry, University of North Carolina at Chapel Hill

Richard Axel, M.D., co-director, Mind Brain Behavior Institute, professor, neuroscience, pathology and cell biology, biochemistry and molecular biophysics, Columbia University Medical Center; investigator, Howard Hughes Medical Institute

Harinder Singh, Ph.D., director, division of immunobiology, Cincinnati Children's Hospital Medical Center

Georgios Skiniotis, Ph.D., professor, molecular and cellular physiology and structural biology, Stanford University

Ed Boyden, Ph.D., associate professor of biological engineering and brain and cognitive science, MIT Media Lab and McGovern Institute; Y. Eva Tan Professor, neurotechnology, Massachusetts Institute of Technology

Partha Mitra, Ph.D., Professor, Cold Spring Harbor Laboratory

John T. Lis, Ph.D., professor, department of molecular biology and genetics, Cornell University

Xavier Darzacq, Ph.D., assistant professor, molecular and cell biology, University of California, Berkeley

Howard C. Hang, Ph.D., Richard E. Salomon Family Associate Professor and head, Laboratory of Chemical Biology and Microbial Pathogenesis, The Rockefeller University

Thomas Rando, M.D., Ph.D., professor, department of neurology and neurological sciences, director, Glenn Center for the Biology of Aging, Stanford University School of Medicine

Bruce Klein, Ph.D., professor, pediatrics, medical microbiology and immunology, University of Wisconsin

Michael Jung, Ph.D., distinguished professor, department of chemistry, University of California, Los Angeles

Zhen Chen, graduate fellow, The Rockefeller University

Dmitri Petrov, Ph.D., Michelle and Kevin Douglas Professor of Biology, Stanford University

Judy Hirst, Ph.D., professor, University of Cambridge

Sergiu Pasca, M.D., assistant professor, Stanford University

Barry S. Coller, M.D., David Rockefeller Professor, physician in chief, vice president for medical affairs, The Rockefeller University, Welcome

Bruce M. Spiegelman, Ph.D., professor of cancer biology, Stanley J. Korsmeyer Professor of Cell Biology and Medicine, Dana-Farber Cancer Institute, Harvard Medical School, New Pathways of Mitochondrial-based Thermogenesis

Marcia C. Haigis, Ph.D., professor, department of cell biology, Harvard Medical School, Mitochondria and Metabolism

Robert Balaban, Ph.D., senior investigator, National Heart, Lung, and Blood Institute, The Mitochondria Reticulum of Muscle Cells

Eileen White, Ph.D., deputy director and associate director for basic science, Rutgers Cancer Institute of New Jersey, distinguished professor of molecular biology and biochemistry, Rutgers University, Role of Mitochondria in Cancer

Eli Y. Adashi, M.D., M.S., professor of medical science, The Warren Alpert Medical School, Brown University, The Prospect of Preventing Mitochondrial DNA Diseases in the U.S.

Susan T. Fiske, Ph.D., Eugene Higgins Professor, department of psychology, Princeton University

Isaac Chiu, Ph.D., assistant professor of microbiology and immunobiology, Harvard Medical School

Natalie Jeremijenko, Ph.D., associate professor of art and art education, Steinhardt School of Culture, Education, and Human Development, New York University

Xin Chen, Ph.D., associate professor, department of biology, Johns Hopkins University

Maureen Murphy, Ph.D., professor and leader, Molecular and Cellular Oncogenesis Program, scientific director, Histotechnology Facility, associate vice president, faculty affairs, The Wistar Institute

Alan Saghatelian, Ph.D., professor, Dr. Frederik Paulsen Chair, Clayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies

Anna Wedell, M.D., Ph.D., head, Center for Inherited Metabolic Diseases; professor, department of molecular medicine and surgery, Science for Life Laboratory, Karolinska Institutet